Literature DB >> 2260205

Visceral leishmaniasis in Sudan. Clinical features.

M Siddig1, H Ghalib, D C Shillington, E A Petersen, S Khidir.   

Abstract

Kala azar is a disease endemic to the Sudan and a cause of major morbidity and mortality to affected patients when the diagnosis or treatment has been delayed. In this report we described the clinical features of 99 parasite proven patients with visceral leishmaniasis. The Sudanese kala azar patient is young in age (teens to 20's), has marked weight loss despite a continuous, excellent appetite and suffers from insomnia, epistaxis and abdominal pain. Hepatosplenomegaly is universally present. Generalized lymphadenopathy is a prominent feature (72%). The high prevalence of lymphadenopathy has a wide range of implications: for diagnosis, i.e., the use of lymph node aspiration; for response to treatment, i.e., the resolution of lymphadenopathy; and for studies of immunoregulation in this systemic infection.

Entities:  

Mesh:

Year:  1990        PMID: 2260205

Source DB:  PubMed          Journal:  Trop Geogr Med        ISSN: 0041-3232


  3 in total

1.  Kala-azar in Trabzon (eastern Black Sea) region of Turkey.

Authors:  H Mocan; Y Gedik; A Okten; E Erduran; N Gacar
Journal:  Indian J Pediatr       Date:  1993 Nov-Dec       Impact factor: 1.967

2.  Visceral Leishmaniasis-Malaria Coinfection and Their Associated Factors in Patients Attending Metema Hospital, Northwest Ethiopia: Suggestion for Integrated Vector Management.

Authors:  Getachew Ferede; Ermias Diro; Sisay Getie; Gebeyaw Getnet; Yegnasew Takele; Anteneh Amsalu; Yitayih Wondimeneh
Journal:  Malar Res Treat       Date:  2017-08-28

3.  Abdominal ultrasound in the diagnostic work-up of visceral leishmaniasis and for detection of complications of spleen aspiration.

Authors:  Rezika Mohammed; Yonathan Gebrewold; Angela Schuster; Helina Fikre; Tigist Mekonnen; Tadele Mulaw; Tadfe Bogale; Florian Vogt; Ermias Diro; Johan van Griensven
Journal:  PLoS Negl Trop Dis       Date:  2021-02-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.